Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes (Q45389188)

14 December 2017

Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes (English)

1 reference

14 December 2017

1

Cornelia Speth

1 reference

14 December 2017

Simon Bredl

2

1 reference

14 December 2017

Magdalena Hagleitner

3

1 reference

14 December 2017

Jens Wild

4

1 reference

14 December 2017

Manfred Dierich

5

1 reference

14 December 2017

Hans Wolf

6

1 reference

14 December 2017

Josef Schroeder

7

1 reference

14 December 2017

Ralf Wagner

8

1 reference

14 December 2017

Ludwig Deml

9

1 reference

14 December 2017

language of work or name

English

0 references

publication date

21 October 2008

1 reference

14 December 2017

1 reference

14 December 2017

382

1 reference

14 December 2017

1

1 reference

14 December 2017

46-58

1 reference

Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Virus-like particles-universal molecular toolboxes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Accelerated clearance of SHIV in rhesus monkeys by virus-like particle vaccines is dependent on induction of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Ultrastructural characterization of human immunodeficiency virus type 1 Gag-containing particles assembled in a recombinant adenovirus vector system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Particle-based vaccines for HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

Baculovirus stimulates antiviral effects in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.08.043

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2008.08.043

1 reference

14 December 2017

1 reference